NCT03064997View on ClinicalTrials.gov

Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 12, 2016

Primary Completion Date

March 1, 2016

Study Completion Date

June 1, 2016

Conditions
Celiac Disease
Interventions
DIETARY_SUPPLEMENT

Synergy 1

a daily dose: 7 g/day of Synergy1 (oligofructose enriched inulin) consumed for 12 weeks together with a strict gluten-free diet

DIETARY_SUPPLEMENT

Placebo

a daily dose: 7 g/day of placebo (maltodextrin) consumed for 12 weeks together with a strict gluten-free diet

Trial Locations (2)

10-561

Regional Specialized Children'S Hospital, Olsztyn

10-748

Institute of Animal Reproduction and Food Research, Polish Academy of Sciences in Olsztyn, Olsztyn

All Listed Sponsors
collaborator

University of Warmia and Mazury

OTHER

lead

Polish Academy of Sciences

OTHER

NCT03064997 - Prebiotic as a Supplement of Gluten-free Diet in the Management of Celiac Disease in Children | Biotech Hunter | Biotech Hunter